- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Interferon Beta 1
Total 20376 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Metastatic Uveal Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous... and other conditionsUnited States
-
University of Colorado, DenverCompleted
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
BiogenRecruitingMultiple SclerosisSpain, Ireland, United States, Germany
-
University Hospital Inselspital, BernePharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 BaselCompletedMultiple SclerosisSwitzerland
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingHepatocellular Carcinoma | Advanced Malignant Solid NeoplasmUnited States
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisItaly, Spain, United States, Germany, France, Serbia, Austria, Brazil, Bulgaria, Canada, Croatia, Estonia, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Sweden, Turkey, Ukraine, United Kingdom, Lithuania, Netherlands, Slovakia and more
-
Karolinska InstitutetMerck Sharp & Dohme LLCCompleted
-
Beth Israel Medical CenterInterMuneCompleted
-
BiogenWithdrawn
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
BiogenCompleted
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Astellas Pharma IncSchering-PloughCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Merkel Cell Carcinoma | Stage IV Merkel Cell CarcinomaUnited States
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
The University of Hong KongHospital Authority, Hong KongUnknown
-
Qassim UniversityUnknown
-
Intarcia TherapeuticsCompletedHepatitis CRussian Federation
-
The University of Hong KongUnknown
-
Shahid Beheshti University of Medical SciencesCompleted
-
University Health Network, TorontoUnknown
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
University of British ColumbiaBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompleted
-
University of California, San FranciscoOregon Health and Science University; National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
InterMuneCompletedChronic Hepatitis CUnited States
-
University Hospital, BordeauxUniversity of BordeauxCompletedCorona Virus Infection | Sars-CoV2France
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and...CompletedRelapsing Remitting Multiple Sclerosis
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
BiogenCompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Oligoastrocytoma, MixedUnited States
-
The University of The West IndiesUnknown
-
Hoffmann-La RocheCompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Shahid Beheshti University of Medical SciencesUnknown
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeTerminatedRespiratory Distress Syndrome, AdultSpain, United Kingdom, France, Italy, Finland, Czechia, Belgium, Germany
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Shanghai Jiao Tong University School of MedicineUnknown2019 Novel Coronavirus InfectionChina
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
National Institute of Allergy and Infectious Diseases...CompletedChronic Granulomatous DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Holy Name Medical Center, Inc.BiogenUnknownMultiple SclerosisUnited States
-
SPP Pharmaclon Ltd.RecruitingPulmonary TuberculosisRussian Federation
-
SPP Pharmaclon Ltd.CompletedCommunity-acquired PneumoniaRussian Federation